Funding for BTEC Meetings
The BTEC is very grateful to each of its funding sources for working together in an innovative way to move epidemiology research forward through its mechanism.
Support for BTEC meetings has been through partnerships, with funds coming from non-profit brain tumor organizations and private and in-kind donations, as well as from the Office of Rare Diseases (ORD) of the National Institutes of Health (NIH), the National Cancer Institute (NCI), and the National Institute of Neurological Diseases and Stroke (NINDS). Among the non-profit partners are the National Brain Tumor Foundation
(San Francisco, CA) and the Pediatric Brain Tumor Foundation (Asheville, NC). Support for individual meetings has been provided by the American Brain Tumor Association, The Preuss Foundation, the Healing Exchange Brain Trust, Cancerfonden (Swedish Cancer Society), Cancerforsknings Fonden Norrland, and the Swedish Pediatric Cancer Foundation. Additional corporate support has come from NeoPharm, Inc., and Schering Plough, Inc. The Central Brain Tumor Registry of the United States (CBTRUS) provides administrative support. Partial support for BTEC's logistical needs is provided by the Division of Cancer Epidemiology and Genetics (DCEG) and NCI's Epidemiology and Genetics Research Program (EGRP), Division of Cancer Control and Population Sciences (DCCPS). Some Consortium investigators have additional grant support for research projects through EGRP.
The most recent BTEC meeting in Heidelberg in April 2008 was cooperatively sponsored by the National Brain Tumor Foundation, BTEC's Sustaining Partner, the Pediatric Brain Tumor Foundation, the European Association for Cancer Research (EARC), the European Association of Neuro-Oncology (EANO), and the Deutsches Krebsforschungszentrum (DKFZ, German Cancer Research Center). EACR was established in 1968 with the aim of advancing cancer research from basic research to prevention, treatment and care. The Association also offers opportunities for Communication, Education, and Training for the Young Cancer Researcher. EANO is the pan-European organization that represents all the medical and scientific disciplines involved in the diagnosis and treatment of tumors of the nervous system. The DKFZ, German Cancer Research Center systematically investigates the mechanisms of cancer development to identify cancer risk factors which may result in new approaches in the prevention, diagnosis, and treatment of cancer.
